AFS
IDXX icon

Anderson Financial Strategies’s Idexx Laboratories IDXX Stock Holding History

Anderson Financial Strategies’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-468
Closed -$197K – 111
2025
Q1 		$197K Buy
+468
New +$203K 0.12% 55

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Anderson Financial Strategies's IDXX Position: Q2 2025 in Review

Anderson Financial Strategies sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 468 shares — an estimated $197K sold.

Anderson Financial Strategies first reported a position in IDXX in Q1 2025 and held it in 1 quarter. The position peaked at $197K in Q1 2025. 1,235 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Anderson Financial Strategies reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
  • Anderson Financial Strategies sold 468 Idexx Laboratories shares in Q2 2025, an estimated $197K.
  • Anderson Financial Strategies first reported a position in Idexx Laboratories in Q1 2025 and held it in 1 quarter.
  • Anderson Financial Strategies's Idexx Laboratories position peaked at $197K in Q1 2025.
  • 1,235 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Anderson Financial Strategies's 13F filing for Q2 2025, filed 11 Aug 2025.